A1 Pharmaceuticals DBSSAS

64886CRF5L4M725HP013

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: 8888
Jurisdiction: United Kingdom
Entity created: September 1, 2023

Address

Country: United Kingdom
Legal address: Unit 20-21 Easter ParkRM13 9BP RainhamUnited Kingdom

Identifier

LEI: 64886CRF5L4M725HP013
Registered: June 19, 2025 at 07:00 AM UTC
Last updated: April 22, 2026 at 10:36 AM UTC
Next renewal: June 18, 2027 at 10:00 PM UTC
Issuer: Nasdaq LEI (485100001PLJJ09NZT59)
Registered with: No Registration Authority available (RA999999)
Verified against: No Registration Authority available (RA999999)
Corroboration: Supplied by the entity, not independently confirmed
GLEIF conformity: Meets the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

Machine access

REST: https://lei.online/v1/entities/64886CRF5L4M725HP013This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search